This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue


Leaving GSK Pro

You are leaving GSK Pro to visit a separate website not associated with GSK Pro, a portal for US Healthcare Professionals.There are website links to third-party sites on GSK Pro. GSK is not responsible for content on third-party websites.




Here you’ll find vaccine product codes and some common administration codes associated with immunization using FLUARIX QUADRIVALENT. Select another vaccine here.

Vaccine administration codes are dependent on the services provided. Please refer to the latest edition of Current Procedural Terminology (CPT) for appropriate administration codes, and the latest edition of International Classification of Diseases (ICD) manual for appropriate diagnosis codes.

Description: FLUARIX QUADRIVALENT is supplied in 0.5-mL single-dose prefilled Tip-Lok syringes.1

Dosage: 0.5 mL1


CPT Code


ICD-10-CM Code2*


MVX Code3


CVX Code4


NDCs (Syringe in package of 10)

2022/2023 Outer Carton

NDC 58160-890-52

2022/2023 Syringe

NDC 58160-890-41

2023/2024 Outer Carton

NDC 58160-909-52

2023/2024 Syringe

NDC 58160-909-41



To promote accuracy, always consult the most current Prescribing Information or product packaging when documenting NDCs.

FLUARIX QUADRIVALENT CPT Code – Immunization Administration Codes5 



If reporting multiple vaccine administrations given to a patient through age 18 on the same date along with counseling by a qualified healthcare professional, report one administration code (90460) for each vaccine administered.7

Diagnosis Codes

Z23 is the ICD-10-CM code used when reporting an encounter for immunization for all vaccines given within the encounter. In some instances, additional ICD-10-CM coding may be needed. 

See all code types

GSK Codes Summary Sheet

Get a PDF of the most current CPT, CVX, MVX, and NDC codes for GSK vaccines.



Find answers to frequently asked questions, along with additional resources, to guide you to the information you need.

Get help

  •   *ICD-10-CM code Z23, Encounter for Immunization, is reported for all vaccines given within an encounter; additional ICD-10-CM coding may be needed.2
  •   Note that some payers require an 11-digit NDC, which involves adding a "0" immediately after the first hyphen in each GSK NDC.8 For example, when reporting NDC 58160-820-11 to TRICARE, it becomes NDC 58160-0820-11.
  •    Adapted from the American Medical Association, CPT 2021 Professional Edition, Current Procedural Terminology (CPT), 2020.


  1. Prescribing Information for FLUARIX QUADRIVALENT.
  2. Centers for Medicare and Medicaid Services. 2021 ICD-10-CM official guidelines for coding and reporting. Accessed February 23, 2021.
  3. Centers for Disease Control and Prevention. Immunization information systems (IIS): HL7 standard code set, MVX – manufacturers of vaccines. Accessed February 23, 2021.
  4. Centers for Disease Control and Prevention. Immunization information systems (IIS): Current HL7 standard code set, CVX – vaccines administered. Accessed February 23, 2021.
  5. American Medical Association. CPT category I new vaccine codes (including incorporation of ACIP abbreviations listing) long descriptors. Accessed February 23, 2021.
  6. Centers for Medicare and Medicaid Services. HCPCS quarterly update. HCPCS January 2021 index. Accessed February 23, 2021.
  7. American Academy of Pediatrics. Bright futures coding for pediatric preventive care 2020. Accessed February 23, 2021.
  8. Humana Military. Office injectable guidelines, national drug code (NDC) pricing and filing tips. Accessed February 23, 2021.

Please note that this website is provided for informational purposes only and is not intended to serve as comprehensive training on medical billing and coding. Additional training on medical coding may be required. The information on this website is believed to be accurate as of the date of publication. Users should independently verify accuracy.

Healthcare providers are responsible for making the ultimate decision on when to use a specific product based on clinical recommendations and how to bill for products and related services rendered. Consult third-party insurers' guidelines for specific information regarding the billing and reporting of services rendered.